Today: 17 May 2026
XRP price today jumps 10% as XRP ETF shares pull in cash — what to watch next
6 January 2026
1 min read

XRP price today jumps 10% as XRP ETF shares pull in cash — what to watch next

New York, Jan 6, 2026, 06:33 EST — Premarket

  • XRP was last up about 10.6% in the past 24 hours, hitting an intraday high near $2.41.
  • Traders pointed to steady demand tied to U.S.-listed spot XRP exchange-traded funds.
  • The next tests include whether XRP holds above $2.30 and a run of U.S. macro data later this week.

XRP rose about 10.6% to $2.36 early Tuesday, lifting the Ripple-linked token to a 24-hour high around $2.41 as buyers extended a sharp start to 2026.

Why it matters now: XRP has led recent moves in major tokens as investors put fresh money to work through U.S.-listed spot XRP exchange-traded funds (ETFs) — stock-like vehicles designed to track the token’s price. Barron’s reported the funds took in $46 million of inflows on Monday, with no daily outflows since launch, citing CoinGlass and CoinDesk data.

The rally also lands at a moment when crypto is trading more like a high-beta risk asset than a hedge, leaving XRP sensitive to shifts in broader sentiment.

In the prior U.S. session, bitcoin climbed to its highest level since mid-November and XRP gained after breaking resistance on heavy volume, while crypto-linked shares such as Coinbase, Robinhood and Strategy posted solid advances, a CoinDesk report carried by KuCoin showed.

Wall Street’s push into regulated crypto products has also broadened. Morgan Stanley has filed with the U.S. Securities and Exchange Commission to launch ETFs linked to bitcoin and solana, a move that underscores the industry’s bid to channel demand through familiar market wrappers.

Spot XRP ETFs began trading in November, including Bitwise’s spot XRP ETF, which the company said would start trading on Nov. 20 under the ticker “XRP.” Bitwise Investments

Technically, traders have treated $2.00 as a “psychological” level — a round number that often acts as support or resistance because it clusters orders. Analyst Itai Smidt wrote on Investing.com that near-term support sat around $2.01–$2.03 and that resistance had been concentrated up to about $2.30, levels now in play as the market decides whether the breakout holds. Investing.com

But the trade is not one-way. “The true black swan, then, could lie elsewhere,” Swissquote Bank senior analyst Ipek Ozkardeskaya said, as Reuters flagged cryptocurrencies’ high-risk profile and their tendency to move alongside tech shares — a mix that can magnify drawdowns when macro nerves spike. Reuters

Investors now pivot to U.S. data with a track record of moving both rates and risk assets: the Employment Situation report is due Friday, Jan. 9 at 8:30 a.m. ET, followed by the Consumer Price Index for December 2025 on Tuesday, Jan. 13 at 8:30 a.m. ET.

Stock Market Today

  • Keyera (TSX:KEY) Shares Rise Amid Valuation Debate
    May 16, 2026, 8:01 PM EDT. Keyera (TSX:KEY) shares rose 4.2% in one day and 17.4% over a month, hitting CA$57.44. The energy infrastructure company's 1-year total shareholder return stands at nearly 40%, with 5-year returns surpassing 150%. Market consensus suggests a slight overvaluation of about 3%, pricing the fair value at CA$56, based on growth in fee-based EBITDA and dividend increases backed by long-term contracts. However, a discounted cash flow (DCF) analysis projects a much higher intrinsic value near CA$170 per share, indicating potential undervaluation. Key risks include regulatory shifts in Western Canada and acquisition integration concerns. Investors face contrasting views between near-term earnings multiples and long-term cash flow forecasts.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Dow Jones today: Futures dip after record close as U.S. jobs report looms
Previous Story

Dow Jones today: Futures dip after record close as U.S. jobs report looms

Arbe Robotics stock jumps premarket on Nvidia link as CES 2026 opens
Next Story

Arbe Robotics stock jumps premarket on Nvidia link as CES 2026 opens

Go toTop